Targeting cancer stem cells pathways for the effective treatment of cancer

dc.contributor.authorDwivedi, A.R
dc.contributor.authorThakur, A
dc.contributor.authorKumar, V
dc.contributor.authorSkvortsova, I
dc.contributor.authorKumar, V.
dc.date.accessioned2020-07-16T07:41:59Z
dc.date.accessioned2024-08-13T12:05:05Z
dc.date.available2020-07-16T07:41:59Z
dc.date.available2024-08-13T12:05:05Z
dc.date.issued2020
dc.description.abstractResistance to chemotherapy and relapse are major hurdles for the effective treatment of cancer. Major reason for this is a small sub population of cancer stem cells (CSCs) and its microenvironment. CSCs are critical driving force for several types of cancer, such as gastric, colon, breast and many more. Hence, for the complete eradication of cancer, it is necessary to develop therapeutic approaches that can specifically target CSCs. Chemical agents that target different proteins involved in CSC signaling pathways, either as single agent or simultaneously targeting two or more proteins have generated promising pre-clinical and clinical results. In the current review article, we have discussed various targets and cellular pathways that can be explored for the effective and complete eradication of CSCs. Some latest developments in the field of design, synthesis and screening of ligands to target cancer stem cells have been summarized in the current review article. � 2020 Bentham Science Publishers.en_US
dc.identifier.doi10.2174/1389450120666190821160730
dc.identifier.issn13894501
dc.identifier.urihttps://kr.cup.edu.in/handle/32116/2695
dc.identifier.urlhttps://www.eurekaselect.com/node/174388/article/targeting-cancer-stem-cells-pathways-for-the-effective-treatment-of-cancer
dc.language.isoenen_US
dc.publisherBentham Science Publishersen_US
dc.subjectCancer stem cellsen_US
dc.subjectHedgehog pathwayen_US
dc.subjectNotch pathwayen_US
dc.subjectNuclear factor-kappa-Ben_US
dc.subjectPI3K/AKT pathwayen_US
dc.subjectWnt Pathwayen_US
dc.titleTargeting cancer stem cells pathways for the effective treatment of canceren_US
dc.title.journalCurrent Drug Targetsen_US
dc.typeReviewen_US
dc.type.accesstypeClosed Accessen_US

Files